PDB33 EVALUATING THE COST-EFFECTIVENESS OF SWITCHING FROM INSULIN GLARGINE TO INSULIN DETEMIR IN PATIENTS WITH TYPE-2 DIABETES IN A CHINESE SETTING: A MODELING STUDY BASED ON THE PREDICTIVE STUDY

Subjects

Subjects :

Oncology
medicine.medical_specialty
genetic structures
business.industry
Insulin glargine
Cost effectiveness
Health Policy
Public Health, Environmental and Occupational Health
Type 2 diabetes
medicine.disease
Internal medicine
Medicine
In patient
business
Insulin detemir
medicine.drug

Details

ISSN :

10983015

Volume :

14

Issue :

3

Database :

OpenAIRE

Journal :

Value in Health

Accession number :

edsair.doi.dedup.....2ce039d9bd3ea6107a4ba4872be209d6

Full Text :

https://doi.org/10.1016/j.jval.2011.02.541